Skip to content ↓

MIT-related firms make best-selling biotechnology drugs

MIT-related companies made nine of the top 10 best-selling biotech drugs in the country in 1994. Those companies include:

��������������������������� Amgen, Inc., which developed Neupogen, Epogen and Procrit. Neupogen boosts white blood cell production and combats infection from chemotherapy, bone marrow transplants and infectious diseases. Epogen is a recombinant human hormone which stimulates red blood cell production for treatment of anemia. Procrit treats anemia associated with chemotherapy and AZT treatment of AIDS.
���������������������������������������������Biogen's Intron A alpha interferon is sold in more than 60 countries for 17 different types of cancers and viral infections, including hepatitis B and C, for which it is the primary treatment. Hairy cell leukemia and Kaposi's sarcoma, an AIDS-related cancer, are among the diseases currently being treated by Intron-A alpha interferon.
���������������������������������������������Genentech, Inc., figures prominently, with five of the top 10 biotech drugs. Its therapeutics treat diabetes (Humulin), hepatitis B (Engerix-B), heart attacks and blood clots (Activase), human growth deficiency (Protropin), and hairy cell leukemia and Kaposi's sarcoma (Roferon-A), among other disorders. Genentech is a pioneer and leader in the biotechnology revolution: the San Francisco-based company was the first major biotechnology company to be formed, in 1976.

Related Topics

More MIT News

Music video screenshot showing about 20 rectangular boxes on a black background featuring MIT Syncopasian members singing

A cappella for a cause

MIT Syncopasian’s musical performance features the poem “Things We Carry On The Sea” by Wang Ping and invites Asian members of the MIT community to help celebrate AAPI Heritage Month.

Read full story